In Ariosa Diagnostics, Inc. v. Sequenom, Inc., 2013 U.S. Dist. LEXUS 156554, the U.S. District Ct. for N.D. Cal., granted summary judgment to Ariosa that the claims of U.S. Patent No. 6,258,540 were invalid as directed to patent-ineligible natural phenomena in combination with conventional sampling and detection techniques. The claim were directed to methods for [...]
The post Ariosa Diagnostics v. Sequenom: Another One Bites The Dust appeared first on Biotechnology Patent Law Blog | Patents4Life by Warren Woessner.